LAVA Therapeutics N.V. Ordinary Shares
Symbol: LVTX (NASDAQ)
1.56
▼ (-0.64%) -0.010
Company Description:
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
Key Stats
- Today's Open: $1.55
- Today's High: $1.577
- Today's Low: $1.555
- Today's Volume: 10.90K
- Yesterday Close: $1.565
- Yesterday High: $1.58
- Yesterday Low: $1.54
- Yesterday Volume: 51.68K
- Last Min Volume: 100
- Last Min High: $1.555
- Last Min Low: $1.555
- Last Min VWAP: $1.555
Company Profile
- Name: LAVA Therapeutics N.V. Ordinary Shares
- Website: https://www.lavatherapeutics.com
- Listed Date: 2021-03-25
- Location: UTRECHT, P7
- Market Status: Active
- CIK Number: 0001840748
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $41.17M
- Round Lot: 100
- Outstanding Shares: 26.31M
- Asset Type: CS
RECENT FILINGS FOR LVTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | SC TO-T/A | View |
| 2025-09-03 | SC 14D9/A | View |
| 2025-09-03 | DEFM14A | View |
| 2025-09-03 | SC TO-T/A | View |
| 2025-08-22 | PREM14A | View |
| 2025-08-15 | DEFA14A | View |
| 2025-08-15 | SC 14D9 | View |
| 2025-08-15 | SC TO-T | View |
| 2025-08-14 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-04 | SC TO-C | View |
| 2025-08-04 | SC14D9C | View |
| 2025-08-04 | DEFA14A | View |
| 2025-08-04 | 8-K | View |
| 2025-06-13 | 8-K | View |
| 2025-05-27 | DEFR14A | View |
| 2025-05-23 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-04-28 | ARS | View |
| 2025-04-28 | DEF 14A | View |
Latest News on LVTX